Compile Data Set for Download or QSAR
maximum 50k data
Found 52 with Last Name = 'bartkovitz' and Initial = 'dj'
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152988(US8993614, 53)
Affinity DataIC50:  3.40nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152989(US8993614, 54)
Affinity DataIC50:  4.21nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152971(BDBM152973 | US8993614, 36)
Affinity DataIC50:  4.21nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152966(US8993614, 30)
Affinity DataIC50:  4.30nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152963(US8993614, 24)
Affinity DataIC50:  4.39nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152975(US8993614, 40)
Affinity DataIC50:  4.44nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152980(BDBM152981 | BDBM152982 | US8993614, 45)
Affinity DataIC50:  4.63nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152990(US8993614, 55)
Affinity DataIC50:  4.75nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152979(US8993614, 44)
Affinity DataIC50:  4.86nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152974(US8993614, 39)
Affinity DataIC50:  5.06nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152977(BDBM152978 | US8993614, 42)
Affinity DataIC50:  5.09nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152986(US8993614, 51)
Affinity DataIC50:  5.14nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152976(US8993614, 41)
Affinity DataIC50:  5.18nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152970(US8993614, 35)
Affinity DataIC50:  5.25nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152977(BDBM152978 | US8993614, 42)
Affinity DataIC50:  5.69nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152964(US8993614, 26)
Affinity DataIC50:  5.82nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152959(US8993614, 20)
Affinity DataIC50:  5.84nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152983(US8993614, 48)
Affinity DataIC50:  6.96nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152961(US8993614, 22)
Affinity DataIC50:  7.13nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152972(US8993614, 37)
Affinity DataIC50:  7.14nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152965(US8993614, 28)
Affinity DataIC50:  8.19nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152968(US8993614, 33)
Affinity DataIC50:  8.22nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152969(US8993614, 34)
Affinity DataIC50:  9.09nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152950(US8993614, 11A)
Affinity DataIC50:  10.1nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152944(US8993614, 5)
Affinity DataIC50:  10.4nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152941(US8993614, 2)
Affinity DataIC50:  10.8nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152962(US8993614, 23)
Affinity DataIC50:  11nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152956(US8993614, 17)
Affinity DataIC50:  11.7nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152953(US8993614, 14)
Affinity DataIC50:  12nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152954(US8993614, 15)
Affinity DataIC50:  12.8nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152957(US8993614, 18)
Affinity DataIC50:  13.1nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152955(US8993614, 16)
Affinity DataIC50:  13.4nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152952(US8993614, 13)
Affinity DataIC50:  14.2nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152945(US8993614, 6)
Affinity DataIC50:  14.5nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152942(US8993614, 3)
Affinity DataIC50:  16.3nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152943(US8993614, 4)
Affinity DataIC50:  18.7nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152991(US8993614, 11B)
Affinity DataIC50:  19.4nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152971(BDBM152973 | US8993614, 36)
Affinity DataIC50:  20.2nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152951(US8993614, 12)
Affinity DataIC50:  23.8nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152985(US8993614, 50)
Affinity DataIC50:  26.5nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152987(US8993614, 52)
Affinity DataIC50:  26.7nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152940(US8993614, 1)
Affinity DataIC50:  29.6nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152980(BDBM152981 | BDBM152982 | US8993614, 45)
Affinity DataIC50:  30.3nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152980(BDBM152981 | BDBM152982 | US8993614, 45)
Affinity DataIC50:  40.8nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152960(US8993614, 21)
Affinity DataIC50:  43.5nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152946(US8993614, 7)
Affinity DataIC50:  45nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152958(US8993614, 19)
Affinity DataIC50:  51.4nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152947(US8993614, 8)
Affinity DataIC50:  53.6nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152949(US8993614, 10)
Affinity DataIC50:  53.6nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetE3 ubiquitin-protein ligase Mdm2(Homo sapiens (Human))
F. Hoffmann-La Roche

US Patent
LigandPNGBDBM152984(US8993614, 49)
Affinity DataIC50:  80.1nMAssay Description:The ability of the compounds to inhibit the interaction between p53 and MDM2 proteins was measured by an HTRF (homogeneous time-resolved fluorescence...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: